Paris, September 8, 2014 – Eurofins Scientific S.E., world leader in food and pharmaceutical products testing and environmental laboratory services, has successfully issued a EUR 150m tap of its hybrid bond governed by Luxembourg law with a perpetual maturity that are listed on the Frankfurt Freieverkehr (unregulated market).
The bonds are to be consolidated and form a single series with the existing EUR 150m deeply subordinated fixed to floating rate bonds issued in 2013.
The transaction enhances balance sheet flexibility to finance the Group’s development plan. The group has acquired 12 laboratories in the first seven months of 2014, including the US ViraCor-IBT Laboratories for 255 m US$.
Incorporated as a European company with its registered office in Luxembourg, Eurofins Scientific is listed on Euronext Paris Stock Exchange.
Eurofins Scientific has appointed HSBC Bank Plc and BNP Paribas as agents to place the new hybrid bond issue with institutional investors across Europe and BNP Paribas Securities Services as tax agent in connection with the new bonds issue.
Eurofins Scientific was advised by JeantetAssociés: Catherine Cathiard, Of Counsel, on corporate law aspects and Jean-François Adelle, Partner, and Thomas Biermeyer, Legal Advisor, on financial law aspects.